Please login to the form below
Coronavirus vaccine
This page shows the latest Coronavirus vaccine news and features for those working in and with pharma, biotech and healthcare.
Trials resume for AZ/Oxford University COVID-19 vaccine
After the Medicines Health Regulatory Authority (MHRA) confirmed that it was safe to do so, clinical trials for the AstraZeneca/Oxford coronavirus vaccine, AZD1222, have resumed in the UK. ... Investigations were conducted to identify if the adverse
Latest news
-
Valneva announces major COVID-19 vaccine partnership with UK government
Two-dose vaccine candidate scheduled to enter first clinical studies in December 2020. ... Valneva is using a proven approach as the base for its vaccine candidate, VLA2001.
-
AZ pauses COVID-19 vaccine study after participant falls ill
The results, published in The Lancet in July, showed that the vaccine produced a robust immune response against the virus in all participants in the study. ... In this early study, the vaccine appeared safe to use, although side effects were common among
-
Top biopharma CEOs sign COVID-19 vaccine safety pledge
These concerns were exacerbated by comments made by US president Donald Trump that a vaccine for the novel coronavirus, SARS-CoV-2, could be available in just a few months. ... The crucial need for ensuring the safety of any potential vaccine has been
-
Translate Bio, Sanofi's COVID-19 vaccine proves promising in animal studies
The US-based biotech signed a deal with Sanofi in March to jointly develop a novel mRNA-based vaccine for COVID-19. ... In June, Sanofi expanded its deal with Translate with an upfront payment of $300m in cash and $125m in an equity investment to broaden
-
Novavax begins phase 2 portion of COVID-19 vaccine trial
Novavax has initiated a phase 2 trial of its COVID-19 vaccine candidate, NVX-CoV2373, in the US and Australia. ... The trial is designed primarily to confirm immunogenicity and safety of the vaccine in adults, with secondary objectives including
More from news
Approximately 11 fully matching, plus 32 partially matching documents found.
Latest Intelligence
-
COVID-19: the race to find a vaccine
2. The race to get a vaccine to market is advancing on multiple fronts. ... The same platform underpins CanSino’s Ebola vaccine that won approval in China in 2017.
-
Developing a COVID-19 vaccine
GlaxoSmithKline has also partnered with Chinese biotech company Clover Biopharmaceuticals on a protein-based coronavirus vaccine candidate, named COVID-19 S-Trimer. ... Translate has already begun to produce multiple mRNA constructs and will use its
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Article: Pricing a coronavirus vaccine
Using findings from our recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine.
-
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it. ... Essentially, people with diabetes will remain at extreme risk, until a coronavirus vaccine becomes available and
-
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we provide custom solutions and strategic recommendations that go beyond research, helping our
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Roche’s Ocrevus boasts positive long-term data in MS
- Roche’s Ocrevus boasts positive long-term data in MS
- Leadership change within Bedrock Group
- Trials resume for AZ/Oxford University COVID-19 vaccine
- AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain
- BMS eyes approval for second Opdivo combo in kidney cancer
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
